Flatiron Health’s Post

Value-based oncology care. A perspective via Blake Madden.

In this interview, Lalan Wilfong, M.D., shares insights from the Community Oncology Alliance’s 2024 Community Oncology Conference panel session titled "Defining Value in Oncology: Executing VBC Accurately & Ethically to Account for All Stakeholders." "Whenever we go into a value-based care arrangement, we want to make sure that the true heart of that is improving patient care and making sure that all of the payment models, quality metrics, and everything else goes toward improving that patient’s outcome and quality of life during the time we're under that model," said Dr Wilfong. Check out the full video here: https://lnkd.in/emqpV3wE #JournalOfClinicalPathways #ValueBasedCare #CancerCare #Oncology #EnhancingOncologyModel #COA2024

Our goal at Zelta is to simplify the complex world of oncology trials. Here is good information about the trends in oncology trials starting in 2024. Thanks Walker Bradham for all that you and the development team do to support our clients to be more efficient and reduce their burden of managing clinical trials. #clinicaldatamanagement #clinicaltrials #zelta #merative

How are payers responding to the growth of competitive therapies in oncology? In this blog, MMIT’s Jory Fleischauer, Pharm.D. takes a look at the data on payer management approaches. Read now: https://ow.ly/gX1t50RlxVc #OncologyTherapies #CancerCare #PayerManagement #Oncology

Hi, I hope this message finds you well. I am writing to share an exciting proposal with you - the establishment of *The Oncology Case Discussion Forum*, an upcoming platform designed exclusively for professionals dealing with oncology patients. The Oncology Case Discussion Forum aims to provide a collaborative space where oncologists can share challenging clinical cases, engage in evidence-based discussions, and access resources to enhance patient care and professional development. Before launching the forum, we would like to gather insights and feedback from esteemed professionals like yourself. Your input will be invaluable in shaping the platform to meet the needs and expectations of the oncology community. Key Objectives of the Survey: - Assess the need and interest in a collaborative case consultation forum among oncologists. - Understand the expectations and preferences regarding the features and functionality of the forum. - Identify potential challenges and concerns that need to be addressed before launching the platform. We invite you to participate in a brief survey to share your thoughts and insights on the Oncology Case Discussion Forum initiative. Your feedback will help us refine the platform and ensure its success. https://lnkd.in/dPS-892g Please find attached document outlining the proposal in more detail. Thank you in advance for your time and contribution. Together, we can create a valuable resource that will benefit the entire oncology community. Should you have any questions or require further information, please feel free to reach out to me directly. Best regards, Dr. Saba Karim

CCF's Chief Patient Officer, Melinda Bachini, co-authored Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers in the American Society of Clinical Oncology (ASCO) Education Book. Melinda contributed a unique look at the specific burdens and barriers patients face when participating in dose-finding oncology trials (DFOTs). Read it here: https://lnkd.in/ggBr7VtQ #patientvoice #patientperspective #clinicaltrials #DFOT #patientadvocacy

The oncology space is no longer subject to minimal payer management. MMIT’s Jory Fleischauer discusses utilization management and the likely rise in competitive contracting coming to this therapeutic area. Read now: https://ow.ly/7X9S50Rlykx #OncologyTherapies #CancerCare #PayerManagement #Oncology

Why Dive Deeper into Oncology Trials in Eastern Europe? If you want to discover this region's unique advantages, from a vast patient pool to specialized CRO services, and how they can improve your Oncology studies, read this article : https://lnkd.in/eViyD9YQ OCT Clinical guides you through the intricacies of Oncology research with proven expertise and results. #oncologyresearch #clinicaltrials #easterneurope #croservices #octclinical 

SignalPath will improve efficiency, ease compliance, boost enrollment, and ensure financial success in clinical trials, leaders said in interviews. Click the link below to read more: https://loom.ly/2o0y49I #TennesseeOncology #Community #Oncology #Cancer #Verily

In this interview with Pharmacy Times, Erica Feinberg, PharmD, BCPS, discusses the new Enhancing Oncology Model (EOM), including contextual examples of the EOM in action and why she thinks the new model is a step in the right direction. #EOM #CMMI #NovelTherapies #CancerCare